EGFR and glioblastoma: Although further investigations are needed, our studies demonstrate that SI306 and its derivatives impact GBM cell survival and that this event is accompanied by a reduction in the expression of EGFRWT and EGFR-vIII in U87 and Cas-1 cells, respectively.